SXTC
vs
S&P 500
SXTC
S&P 500
Over the past 12 months, SXTC has underperformed S&P 500, delivering a return of -100% compared to the S&P 500's +33% growth.
Stocks Performance
SXTC vs S&P 500
Performance Gap
SXTC vs S&P 500
Performance By Year
SXTC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
China SXT Pharmaceuticals Inc
Glance View
China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 96 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.
